Kyoung-ah Kim

Goyang, Republic of Korea

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 29 publications

Clinical Outcomes of Contemporary Bariatric Surgical Procedures: A Nationwide Cohort Study.

Clinical Outcomes of Contemporary Bariatric Surgical Procedures: A Nationwide Cohort Study.

Journal: Journal of obesity & metabolic syndrome

Published: June 15, 2026

Real-world risk factors and clinical implications of early estimated glomerular filtration rate decline after sodium-glucose cotransporter-2 inhibitor therapy.

Real-world risk factors and clinical implications of early estimated glomerular filtration rate decline after sodium-glucose cotransporter-2 inhibitor therapy.

Journal: Journal of diabetes investigation

Published: March 24, 2026

Clinical Utility of Salivary Steroid Profiling for the Differential Diagnosis of Adrenal Diseases.

Clinical Utility of Salivary Steroid Profiling for the Differential Diagnosis of Adrenal Diseases.

Journal: The Journal of clinical endocrinology and metabolism

Published: May 01, 2025

Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy.

Add-On Treatment with Gliclazide for Cancer Patients with Type 2 Diabetes Undergoing Cyclic Glucocorticoid-Containing Chemotherapy.

Journal: Biomedicines

Published: April 03, 2025

Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction.

Discrepancies in Dapagliflozin Response in Terms of Glycemic Control and Body Weight Reduction.

Journal: Endocrinology and metabolism (Seoul, Korea)

Published: August 18, 2024

Efficacy and safety of dapagliflozin add-on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study.

Efficacy and safety of dapagliflozin add-on to evogliptin plus metformin therapy in patients with type 2 diabetes: A randomized, double-blind, placebo-controlled study.

Journal: Diabetes, obesity & metabolism

Published: April 20, 2024

Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).

Study Design and Protocol for a Randomized Controlled Trial to Assess Long-Term Efficacy and Safety of a Triple Combination of Ezetimibe, Fenofibrate, and Moderate-Intensity Statin in Patients with Type 2 Diabetes and Modifiable Cardiovascular Risk Factors (ENSEMBLE).

Journal: Endocrinology and metabolism (Seoul, Korea)

Published: April 01, 2024

Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants.

Pharmacokinetics of a Fixed-Dose Combination Product of Amlodipine, Losartan, Ezetimibe, and Rosuvastatin and Its Comparison with Co-administration of Four Individual Components in Healthy Participants.

Journal: Drugs in R&D

Published: March 24, 2024

Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study.

Dual add-on therapy of gemigliptin and dapagliflozin in patients with type 2 diabetes inadequately controlled with metformin alone: The SOLUTION 2 study.

Journal: Diabetes, obesity & metabolism

Published: January 10, 2024

Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.

Effects of dapagliflozin compared with glimepiride on body composition in Asian patients with type 2 diabetes inadequately controlled with metformin: The BEYOND study.

Journal: Diabetes, obesity & metabolism

Published: December 23, 2022

The effect of metabolic dysfunction-associated fatty liver disease and diabetic kidney disease on the risk of hospitalization of heart failure in type 2 diabetes: a retrospective cohort study.

The effect of metabolic dysfunction-associated fatty liver disease and diabetic kidney disease on the risk of hospitalization of heart failure in type 2 diabetes: a retrospective cohort study.

Journal: Diabetology & metabolic syndrome

Published: November 18, 2022

Association between exercise and risk of fractures in new-onset type 2 diabetes: a retrospective cohort study.

Association between exercise and risk of fractures in new-onset type 2 diabetes: a retrospective cohort study.

Journal: Archives of osteoporosis

Published: October 26, 2022

Showing 1-12 of 29

Last Updated: 09/26/2026